Finance

Lists
LH:NYSE
Labcorp Holdings Inc
USD 288,91
+2,65%
(+7,45) 1D
23 Jul., 13:33:34 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LH...
Open
USD 290,30
High
USD 298,46
Low
USD 286,50
Mkt. cap
23,69 mjd
Avg. vol.
654,01 k
Volume
681,20 k
Dividend
1,00%
Quarterly dividend
USD 0,72
Ex-dividend date
29 Mei 2026
P/E ratio
25,60
52-wk high
USD 298,46
52-wk low
USD 244,52
EPS
USD 11,29
Beta
0,89
Shares outstanding
82,00 m
No. of employees
71 k
Open
USD 290,30
High
USD 298,46
Low
USD 286,50
Mkt. cap
23,69 mjd
Avg. vol.
654,01 k
Volume
681,20 k
Dividend
1,00%
Quarterly dividend
USD 0,72
Ex-dividend date
29 Mei 2026
P/E ratio
25,60
52-wk high
USD 298,46
52-wk low
USD 244,52
EPS
USD 11,29
Beta
0,89
Shares outstanding
82,00 m
No. of employees
71 k
News stories
From sources across the web
Profile
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S. Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program. Wikipedia
About Labcorp Holdings Inc
CEOAdam H. Schechter
Employees71 k
Founded1978
HeadquartersBurlington, Noord-Carolina, Verenigde State van Amerika
SectorHealth care provider
Websitelabcorp.com
Analyst ratings
Based on 8 analysts giving stock ratings to LH in the past 3 months
Strong buy
Buy
7
Hold
1
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for LH in the last 3 months.
Highest
Current USD 288,91
USD 334,00 (+15,61%)
Average
USD 313,43 (+8,49%)
Lowest
USD 290,00 (+0,38%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Ryskin
Bank of America Securities
Buy
Maintained
USD 320,00
+10,8%
07/13/2026
David Toung
Argus Research
Buy
Maintained
USD 310,00
+7,3%
06/02/2026
Unknown Analyst
Mizuho Securities
Buy
Reiterated
USD 320,00
+10,8%
05/27/2026
David S Macdonald
Truist Financial
Buy
Reiterated
USD 320,00
+10,8%
05/04/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
USD 300,00
+3,8%
05/01/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
USD 334,00
+15,6%
05/01/2026
Luke Sergott
Barclays
Hold
Reiterated
USD 290,00
+0,4%
05/01/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
04/30/2026
David Westenberg
Piper Sandler
Hold
Reiterated
USD 300,00
+3,8%
02/24/2026
Erin Wright
Morgan Stanley
Buy
Maintained
USD 308,00
+6,6%
02/18/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
USD 330,00
+14,2%
02/18/2026
Ann Hynes
Mizuho Securities
Buy
Reiterated
USD 320,00
+10,8%
02/18/2026
Next call oor 7 dae
Do. 30 Jul., 15:00
Fiscal period
Q2 2026
EPS / Est. (USD)
- / USD 4,77
Revenue / Est. (USD)
- / 3,71 mjd
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
3,53 mjd
3,56 mjd
3,52 mjd
3,54 mjd
Cost of goods sold
2,48 mjd
2,54 mjd
2,52 mjd
2,52 mjd
Cost of revenue
2,48 mjd
2,54 mjd
2,52 mjd
2,52 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
579,30 m
552,40 m
549,70 m
551,00 m
Operating expense
647,60 m
621,90 m
622,30 m
626,60 m
Total operating expenses
3,13 mjd
3,16 mjd
3,14 mjd
3,15 mjd
Operating income
398,60 m
403,20 m
370,90 m
387,20 m
Other non operating income
-1,40 m
700,00 k
1,90 m
-600,00 k
EBT including unusual items
304,70 m
337,00 m
190,60 m
319,70 m
EBT excluding unusual items
340,10 m
341,30 m
315,20 m
333,20 m
Income tax expense
66,40 m
75,50 m
25,70 m
41,70 m
Effective tax rate
21,79%
22,40%
13,48%
13,04%
Other operating expenses
-
-
-
-
Net income
237,90 m
261,10 m
164,70 m
277,80 m
Net profit margin
6,74%
7,33%
4,68%
7,85%
Earnings per share
4,35
4,18
4,07
4,25
Interest and investment income
1,70 m
3,50 m
3,50 m
12,20 m
Interest expense
-57,10 m
-56,00 m
-55,00 m
-55,10 m
Net interest expenses
-55,40 m
-52,50 m
-51,50 m
-42,90 m
Depreciation and amortization charges
-
-
-
-
EBITDA
568,90 m
574,20 m
549,40 m
560,50 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer